- Gorelik L, Lerner M, Bixler S, et al. Anti-JCV virus antibodies: implications for PML risk stratification. Ann Neurol. 2010;68(3):295-303.
- Data on file, Biogen Idec.
Second Generation STRATIFY JCV
- STRATIFY JCV is an analytically validated blood test that can determine whether a patient has been exposed to the JC virus (JCV)2
- The results can be used to help assess an individual patient's
risk of developing progressive multifocal leukoencephalopathy (PML), a demyelinating disease caused by JCV1
STRATIFY JCV testing service is provided by Focus Diagnostics, a Quest Diagnostics subsidiary, and detects antibodies to JC virus to aid in risk stratification for progressive multifocal leukoencephalopathy in multiple sclerosis patients. The test is based on technology Focus Diagnostics licensed exclusively from Biogen Idec.